The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Best Practiceees in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center.

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Video Viewpoint Strategy Session: Update on Immunotherapeutic Strategies for Advanced Merkel Cell CarcinomaIt has been reviewed by Shailender Bhatia, MD, Associate Professor, University of Washington School of Medicine, Fred Hutchinso Cancer Research Center, and Ciara Kelly, MBBCh, BAO, Assistant Attending Physician, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center.

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Video Viewpoint Strategy Session: Advances in the Treatment of Relapsed/Refractory Immune Thrombocytopenia. It has been reviewed by Keith McCrae, MD and  Phyllis McKiernan, APN, MSN, OCN® (2021).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Video Viewpoint Strategy Session: Expert Guidance on New Advances in Renal Cell Carcinoma. It has been reviewed by Bradley McGregor, MD, and Robert Motzer, MD (2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer. It has been reviewed by Sara M. Tolaney, MD, MPH; Ira J. Bleiweiss, MD; and Mikel Ross, MSN, RN, AGPCNP-BC, OCN^®, CBCN^® (2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME-approved virtual tumor board, Optimizing Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma. It has been reviewed by Loretta J. Nastoupil, MD; Reem Karmali, MD, MS; and Francisco Vega, MD, PhD (November 2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Advanced Soft Tissue Sarcoma. It has been reviewed by Vicki L. Keedy, MD, MSCI; Brian P. Rubin, MD, PhD; and Kathleen Polson, NP (2020).